Status:
COMPLETED
Use of Thalidomide in Patients With Arachnoiditis
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Celgene Corporation
Conditions:
Arachnoiditis
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
This pilot study will evaluate whether thalidomide decreases pain in patients with arachnoiditis.
Detailed Description
Arachnoiditis, a neuropathic disease caused by inflamation of the arachnoid membrane that surrounds and protects the spinal nerves,can result in a debilitating state that is characterized by numbing a...
Eligibility Criteria
Inclusion
- Radiographically confirmed Arachnoiditis
- Involvement of the lower limb(s)
Exclusion
- Subjects with baseline peripheral neuropathy to include diabetic neuropathy and other metabolic or toxic neuropathies.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2006
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00284505
Start Date
July 1 2005
End Date
July 1 2006
Last Update
December 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University Pain Management Center
St Louis, Missouri, United States, 63141